Zur Bedeutung des Solcoseryl® bei Infertilität*

The effect of different Solcoseryl (Solco, Basel, Switzerland) concentrations on the motility of human sperm were tested on 37 ejaculates taken from two subject groups. Altogether 111 motility studies were performed using the eosine vitality test. In view of the considerable variations associated with motility tests, Solcoseryl appeared to have no effect on sperm motility in the majority of cases in group 1. The observed improvement in motility (20%) was countered by still greater motility losses (27%). The results, obtained by studies on selected asthenospermia (group 2) are different, however: the 26% increase in motility was opposed to a motility loss of only 17%. A Solcoseryl concentration of 50% was found to have the best effects on motility. A general rise in sperm motility by means of Solcoseryl cannot be considered, although tests would appear advisable in isolated instances. Solcoseryl may be a valuable protective resuspension agent for insemination purposes.